216095265	216095265	CD	B-NP	O
|	|	NN	I-NP	O
BMH	BMH	NN	I-NP	O
|	|	NN	I-NP	O
79004464	79004464	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3853101	3853101	CD	B-NP	O
|	|	CC	I-NP	O
2/15/2006	2/15/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CELLULITIS	CELLULITIS	NN	I-NP	I-protein
RIGHT	RIGHT	NN	I-NP	I-protein
FOOT	FOOT	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/5/2006	8/5/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/10/2006	3/10/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
GLANDEN	GLANDEN	NN	B-NP	O
,	,	,	O	O
MODESTO	MODESTO	NNP	B-NP	O
HAL	HAL	NNP	I-NP	O
MD	MD	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Chronic	Chronic	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
atheroemboli	atheroemboli	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

PROCEDURES	PROCEDURES	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

6/28/2006	6/28/2006	CD	B-NP	O
,	,	,	O	O
aortogram	aortogram	NN	B-NP	O
bilateral	bilateral	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
runoff	runoff	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Zumstein	Zumstein	NNP	I-NP	B-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

9/22/2006	9/22/2006	CD	B-NP	O
left	leave	VBD	B-VP	O
femoral	femoral	JJ	B-ADJP	O
to	to	TO	B-VP	O
dorsalis	dorsalis	VB	I-VP	O
pedis	pedis	NN	B-NP	O
bypass	bypass	NN	I-NP	O
graft	graft	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Saltzberg	Saltzberg	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
75-year-old	75-year-old	JJ	I-NP	O
former	former	JJ	I-NP	O
smoker	smoker	NN	I-NP	O
with	with	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
2006	2006	CD	I-NP	O
and	and	CC	O	O
October	October	NNP	B-NP	O
2006	2006	CD	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
in	in	IN	B-PP	O
clinic	clinic	NN	B-NP	O
with	with	IN	B-PP	O
progressively	progressively	RB	B-ADVP	O
worsening	worsen	VBG	B-VP	O
bilateral	bilateral	JJ	B-NP	O
foot	foot	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
foot	foot	NN	B-NP	O
mottling	mottling	NN	I-NP	O
and	and	CC	O	O
new	new	JJ	B-NP	O
ulcerations	ulceration	NNS	I-NP	O
.	.	.	O	O

Concern	Concern	NN	B-NP	O
for	for	IN	B-PP	O
atheroembolization	atheroembolization	NN	B-NP	O
was	be	VBD	B-VP	O
raised	raise	VBN	I-VP	O
following	follow	VBG	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
followup	followup	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
persistent	persistent	JJ	B-NP	O
ulcerations	ulceration	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
erythema	erythema	NN	B-NP	O
.	.	.	O	O

Pedal	Pedal	JJ	B-NP	O
signals	signal	NNS	I-NP	O
by	by	IN	B-PP	O
Doppler	Doppler	NNP	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
from	from	IN	B-PP	O
clinic	clinic	NN	B-NP	O
for	for	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
and	and	CC	O	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
vascular	vascular	JJ	I-NP	O
anatomy	anatomy	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
denied	deny	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
described	describe	VBD	B-VP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
as	as	IN	B-PP	O
burning	burning	NN	B-NP	O
in	in	IN	B-PP	O
both	both	CC	O	O
her	her	PRP$	B-NP	O
feet	foot	NNS	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
relief	relief	NN	I-NP	O
obtained	obtain	VBN	B-VP	O
when	when	WRB	B-ADVP	O
dangling	dangle	VBG	B-VP	O
the	the	DT	B-NP	O
feet	foot	NNS	I-NP	O
off	off	IN	B-PP	O
the	the	DT	B-NP	O
bed	bed	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

End-stage	End-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
.	.	.	O	O

a.	a.	RB	B-NP	O
5/19/2004	5/19/2004	CD	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
radiocephalic	radiocephalic	JJ	B-NP	O
AV	AV	NN	I-NP	O
fistula	fistula	NN	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Mcbroom	Mcbroom	NNP	I-NP	O
b.	b.	NN	I-NP	O
3/18/2005	3/18/2005	CD	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
AV	AV	NN	B-NP	O
fistula	fistula	NN	I-NP	O
cephalic	cephalic	JJ	I-NP	O
transposition	transposition	NN	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Roskovensky	Roskovensky	NNP	I-NP	O
c.	c.	NN	I-NP	O
1/13/2006	1/13/2006	CD	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
AVF	AVF	NN	B-NP	O
revision	revision	NN	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Espinel	Espinel	NNP	I-NP	O
d.	d.	NNP	I-NP	O
9/17/2006	9/17/2006	CD	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
right	right	JJ	I-NP	O
IJ	IJ	NN	I-NP	O
tunneled	tunnel	VBD	B-VP	O
hemodialysis	hemodialysis	NN	B-NP	O
catheter	catheter	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CAD	CAD	NN	B-NP	O
.	.	.	O	O

a.	a.	LS	B-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
non-ST	non-ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

b.	b.	LS	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
1/13/2006	1/13/2006	CD	B-NP	O
with	with	IN	B-PP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
drug-eluting	drug-eluting	JJ	I-NP	O
stent	stent	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
.	.	.	O	O

c.	c.	LS	B-NP	O
Status	Status	NNP	I-NP	O
post	post	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
8/6/2006	8/6/2006	CD	I-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
circumflex	circumflex	NN	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
noncritical	noncritical	JJ	B-ADJP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

a.	a.	RB	B-NP	O
2/14/2006	2/14/2006	CD	I-NP	O
,	,	,	O	O
Echo	Echo	NNP	B-NP	O
showing	show	VBG	B-VP	O
concentric	concentric	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
45-50	45-50	CD	B-NP	O
%	%	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
from	from	IN	B-PP	O
2004	2004	CD	B-NP	O
.	.	.	O	O

Septal	Septal	JJ	B-NP	O
and	and	CC	I-NP	O
inferior	inferior	JJ	I-NP	O
wall	wall	NN	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
left	left	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-ADJP	O
to	to	TO	B-PP	O
severe	severe	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
mild	mild	JJ	B-NP	O
TR	TR	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

COPD	COPD	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
intermittent	intermittent	JJ	B-NP	O
home	home	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Obstructive	Obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Dyslipidemia	Dyslipidemia	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Gout	Gout	NNP	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

GERD	GERD	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Cardizem	Cardizem	NN	B-NP	B-protein
60	60	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Atrovent	Atrovent	IN	B-PP	O
2	2	CD	B-NP	O
puffs	puff	NNS	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Albuterol	Albuterol	NN	B-NP	B-protein
2	2	CD	B-NP	I-protein
puffs	puff	NNS	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

Renagel	Renagel	NNP	B-NP	O
806	806	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
every	every	DT	B-NP	O
meal	meal	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Allopurinol	Allopurinol	DT	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Zaroxylyn	Zaroxylyn	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
10	10	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
nightly	nightly	RB	B-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Valium	Valium	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

Isordil	Isordil	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Hydralazine	Hydralazine	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Zantac	Zantac	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
17	17	CD	I-NP	I-protein
.	.	.	O	O

Aciphex	Aciphex	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Neurontin	Neurontin	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
post-dialysis	post-dialysis	NN	I-NP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Metamucil	Metamucil	NNP	B-NP	O
.	.	.	O	O

20	20	CD	B-NP	O
.	.	.	O	O

Nitroglycerine	Nitroglycerine	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
21	21	CD	I-NP	O
.	.	.	O	O

Procrit	Procrit	NNP	B-NP	O
40	40	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
every	every	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

22	22	CD	B-NP	O
.	.	.	O	O

Lilly	Lilly	RB	B-NP	O
insulin	insulin	NN	I-NP	O
pen	pen	NN	I-NP	O
,	,	,	O	O
unknown	unknown	JJ	B-NP	O
dosage	dosage	NN	I-NP	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
every	every	DT	B-NP	O
evening	evening	NN	I-NP	O
.	.	.	O	O

23	23	CD	B-NP	O
.	.	.	O	O

Loperamide	Loperamide	NN	B-NP	B-protein
2	2	CD	B-NP	I-protein
tabs	tab	NNS	I-NP	I-protein
p.o.	p.o.	RB	B-ADVP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

24	24	CD	B-NP	O
.	.	.	O	O

Ambien	Ambien	IN	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
nightly	nightly	RB	B-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
ALLERGIES	ALLERGIES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Penicillin	Penicillin	NN	B-NP	O
causing	cause	VBG	B-VP	O
tongue	tongue	NN	B-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Morphine	Morphine	NN	B-NP	O
causing	cause	VBG	B-VP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Codeine	Codeine	NN	B-NP	O
causing	cause	VBG	B-VP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
change	change	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Dilaudid	Dilaudid	VBD	B-VP	O
causing	cause	VBG	I-VP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
change	change	NN	I-NP	O
,	,	,	O	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	NNP	B-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Tobacco	Tobacco	NNP	B-NP	O
,	,	,	O	O
80-pack-year	80-pack-year	JJ	B-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
quit	quit	VBD	B-VP	O
in	in	IN	B-PP	O
1990	1990	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

No	No	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
temperature	temperature	NN	B-NP	O
of	of	IN	B-PP	O
99.2	99.2	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
121	121	NN	B-NP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
116/60	116/60	CD	I-NP	O
,	,	,	O	O
saturating	saturate	VBG	B-VP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Pulse	Pulse	NN	B-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
palpable	palpable	JJ	I-NP	O
femoral	femoral	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
and	and	CC	O	O
biphasic	biphasic	JJ	B-NP	O
dopplerable	dopplerable	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
DP	DP	NN	B-NP	O
and	and	CC	I-NP	O
PT	PT	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
showed	show	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
mottling	mottling	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
toes	toe	NNS	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
open	open	JJ	I-NP	O
0.5	0.5	CD	I-NP	O
cm	cm	NN	I-NP	O
ulceration	ulceration	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
base	base	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
fourth	fourth	JJ	I-NP	O
toe	toe	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
toes	toe	NNS	I-NP	O
are	be	VBP	B-VP	O
exquisitely	exquisitely	RB	I-VP	O
tender	tender	VB	I-VP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
.	.	.	O	O

Sensation	Sensation	NN	B-NP	O
is	be	VBZ	B-VP	O
decreased	decrease	VBN	I-VP	O
but	but	CC	O	O
equal	equal	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
75-year-old	75-year-old	JJ	I-NP	O
female	female	JJ	I-NP	O
vasculopath	vasculopath	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
suspected	suspect	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
contributing	contribute	VBG	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
new	new	JJ	I-NP	O
ulcerations	ulceration	NNS	I-NP	O
and	and	CC	O	O
progressively	progressively	RB	B-VP	O
worsening	worsen	VBG	I-VP	O
wrist	wrist	JJ	B-NP	O
pain	pain	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
exacerbating	exacerbate	VBG	I-NP	O
factor	factor	NN	I-NP	O
to	to	TO	B-PP	O
likely	likely	JJ	B-NP	O
atheroembolic	atheroembolic	JJ	I-NP	O
phenomenon	phenomenon	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
coronary	coronary	JJ	B-NP	O
catheterizations	catheterization	NNS	I-NP	O
earlier	earlier	RBR	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
year	year	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
broad-spectrum	broad-spectrum	NN	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
and	and	CC	I-NP	O
plan	plan	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
MRA	MRA	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
her	her	PRP$	B-NP	O
anatomy	anatomy	NN	I-NP	O
.	.	.	O	O

Unfortunately	Unfortunately	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
the	the	DT	B-NP	O
MR	MR	NN	I-NP	B-protein
and	and	CC	O	O
did	do	VBD	B-VP	O
experience	experience	VB	I-VP	O
some	some	DT	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
changes	change	NNS	I-NP	O
that	that	WDT	B-NP	O
prevented	prevent	VBD	B-VP	O
further	further	JJ	B-NP	O
noninvasive	noninvasive	JJ	I-NP	O
imaging	imaging	NN	I-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
some	some	DT	B-NP	O
narcotic	narcotic	JJ	I-NP	O
following	follow	VBG	B-PP	O
her	her	PRP$	B-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
round	round	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
ensuing	ensue	VBG	I-NP	O
days	day	NNS	I-NP	O
she	she	PRP	B-NP	O
required	require	VBD	B-VP	O
rather	rather	RB	B-NP	O
significant	significant	JJ	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Zyprexa	Zyprexa	NNP	B-NP	O
and	and	CC	I-NP	O
Haldol	Haldol	NNP	I-NP	O
to	to	TO	B-VP	O
contain	contain	VB	I-VP	O
agitation	agitation	NN	B-NP	O
and	and	CC	I-NP	O
delirium	delirium	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
also	also	RB	I-VP	O
get	get	VB	I-VP	O
physical	physical	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
violent	violent	JJ	I-ADJP	O
.	.	.	O	O

This	This	DT	B-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
sedate	sedate	VB	I-VP	O
her	her	PRP	B-NP	O
sufficiently	sufficiently	RB	B-ADVP	O
and	and	CC	O	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
following	following	JJ	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
manage	manage	VB	I-VP	O
to	to	TO	I-VP	O
calm	calm	VB	I-VP	O
significantly	significantly	RB	B-ADVP	O
and	and	CC	O	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
appear	appear	VB	I-VP	O
very	very	RB	B-ADJP	O
emotionally	emotionally	RB	I-ADJP	O
labile	labile	JJ	I-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
and	and	CC	O	O
incredibly	incredibly	RB	B-ADJP	O
remorseful	remorseful	JJ	I-ADJP	O
for	for	IN	B-PP	O
previous	previous	JJ	B-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
6/28/2006	6/28/2006	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
offered	offer	VBN	I-VP	O
an	an	DT	B-NP	O
angiogram	angiogram	NN	I-NP	O
to	to	TO	B-VP	O
delineate	delineate	VB	I-VP	O
aortic	aortic	JJ	B-NP	O
and	and	CC	I-NP	O
bilateral	bilateral	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
runoff	runoff	NN	I-NP	O
anatomy	anatomy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
tolerate	tolerate	VB	I-VP	O
this	this	DT	B-NP	O
well	well	NN	I-NP	O
under	under	IN	B-PP	O
simple	simple	JJ	B-NP	O
IV	IV	CD	I-NP	O
conscious	conscious	JJ	I-NP	O
sedation	sedation	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
showed	show	VBD	B-VP	O
chronic	chronic	JJ	B-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
collateralization	collateralization	NN	B-NP	O
and	and	CC	O	O
very	very	RB	B-NP	O
poor	poor	JJ	I-NP	O
inflow	inflow	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
bilateral	bilateral	JJ	I-NP	O
feet	foot	NNS	I-NP	O
with	with	IN	B-PP	O
essentially	essentially	RB	B-NP	O
one	one	CD	I-NP	O
vessel	vessel	NN	I-NP	O
run	run	VBN	B-VP	O
off	off	RP	B-PRT	O
on	on	IN	B-PP	O
either	either	DT	B-NP	O
side	side	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
extensive	extensive	JJ	B-NP	O
discussions	discussion	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
family	family	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
agree	agree	VB	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
left	leave	VBN	I-NP	O
femoral	femoral	JJ	B-ADJP	O
to	to	TO	B-VP	O
dorsalis	dorsalis	VB	I-VP	O
pedis	pedis	NN	B-NP	O
bypass	bypass	NN	I-NP	O
graft	graft	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
9/22/2006	9/22/2006	CD	B-NP	O
without	without	IN	B-PP	O
complication	complication	NN	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
see	see	VB	I-VP	O
the	the	DT	B-NP	O
operative	operative	JJ	I-NP	O
note	note	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
details	detail	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
tolerate	tolerate	VB	I-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

By	By	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
ambulating	ambulate	VBG	B-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
rolling	rolling	NN	I-NP	O
walker	walker	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
analgesics	analgesic	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
narcotic	narcotic	JJ	B-ADJP	O
based	base	VBN	B-VP	O
.	.	.	O	O

Cardiology	Cardiology	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
to	to	TO	B-VP	O
optimize	optimize	VB	I-VP	O
her	her	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
OR	OR	NN	I-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Fugle	Fugle	NNP	I-NP	O
did	do	VBD	B-VP	O
make	make	VB	I-VP	O
some	some	DT	B-NP	O
recommendations	recommendation	NNS	I-NP	O
including	include	VBG	B-PP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
preserved	preserve	VBN	I-VP	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
beta	beta	NN	I-NP	O
blockade	blockade	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
tolerate	tolerate	VB	I-VP	O
hemodialysis	hemodialysis	NN	B-NP	O
throughout	throughout	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
without	without	IN	B-PP	O
undue	undue	JJ	B-NP	O
difficulty	difficulty	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
on	on	IN	B-PP	O
one	one	CD	B-NP	O
occasion	occasion	NN	I-NP	O
experience	experience	NN	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
following	follow	VBG	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
that	that	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
own	own	JJ	I-NP	O
accord	accord	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
events	event	NNS	I-NP	O
or	or	CC	B-PP	O
in	in	IN	B-PP	O
evidence	evidence	NN	B-NP	O
by	by	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
or	or	CC	B-PP	O
by	by	IN	B-PP	O
following	follow	VBG	B-VP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
and	and	CC	O	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
activity	activity	NN	B-NP	O
with	with	IN	B-PP	O
very	very	RB	B-NP	O
strong	strong	JJ	I-NP	O
support	support	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
services	service	NNS	B-NP	O
for	for	IN	B-PP	O
wound	wound	JJ	B-NP	O
checks	check	NNS	I-NP	O
and	and	CC	O	O
home	home	NN	B-NP	O
safety	safety	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sedlachek	Sedlachek	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Touchdown	Touchdown	IN	B-PP	O
weightbearing	weightbeare	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
heel	heel	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
keep	keep	VB	I-VP	O
legs	leg	NNS	B-NP	O
in	in	IN	B-PP	O
dependent	dependent	JJ	B-NP	O
position	position	NN	I-NP	O
for	for	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
10	10	CD	I-NP	O
minutes	minute	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
to	to	TO	I-VP	O
use	use	VB	I-VP	O
the	the	DT	B-NP	O
walker	walker	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
cane	cane	NN	I-NP	O
as	as	IN	B-SBAR	O
instructed	instruct	VBN	B-VP	O
by	by	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Legs	Leg	NNS	B-NP	O
are	be	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
elevated	elevate	VBN	I-VP	O
as	as	RB	B-ADVP	O
much	much	RB	I-ADVP	O
as	as	IN	B-PP	O
possible	possible	JJ	B-ADJP	O
while	while	IN	B-SBAR	O
sitting	sit	VBG	B-VP	O
or	or	CC	I-VP	O
lying	lie	VBG	I-VP	O
down	down	RP	B-PRT	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

All	All	DT	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
resumed	resume	VBN	I-VP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
Lopressor	Lopressor	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
changed	change	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Huggins	Huggins	NNP	I-NP	O
to	to	TO	B-PP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

VNA	VNA	NN	B-NP	B-protein
was	be	VBD	B-VP	O
ordered	order	VBN	I-VP	O
to	to	TO	B-VP	O
assist	assist	VB	I-VP	O
with	with	IN	B-PP	O
wound	wound	JJ	B-NP	O
care	care	NN	I-NP	O
including	include	VBG	B-PP	O
Betadine	Betadine	NN	B-NP	O
paint	paint	NN	I-NP	O
to	to	TO	B-PP	O
incisions	incision	NNS	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Showering	Shower	VBG	B-VP	O
only	only	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
bathing	bathing	NN	I-NP	O
or	or	CC	I-NP	O
immersion	immersion	NN	I-NP	O
in	in	IN	B-PP	O
water	water	NN	B-NP	O
for	for	IN	B-PP	O
prolonged	prolonged	JJ	B-NP	O
periods	period	NNS	I-NP	O
of	of	IN	B-PP	O
time	time	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Follow-up	Follow-up	JJ	B-NP	O
visit	visit	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
scheduled	schedule	VBN	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Amorose	Amorose	NNP	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Morici	Morici	NNP	I-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-PP	O
every	every	DT	B-NP	O
four	four	CD	I-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Albuterol	Albuterol	NNP	B-NP	O
inhaler	inhaler	IN	B-PP	O
2	2	CD	B-NP	O
puffs	puff	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Allopurinol	Allopurinol	DT	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Calcitriol	Calcitriol	NN	B-NP	O
1.5	1.5	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
every	every	DT	B-NP	O
Monday	Monday	NNP	I-NP	O
and	and	CC	O	O
every	every	DT	B-NP	O
Friday	Friday	NNP	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Darbepoetin	Darbepoetin	NN	B-NP	O
alfa	alfa	NN	I-NP	O
100	100	CD	I-NP	O
mcg	mcg	NN	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
every	every	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Ferrous	Ferrous	JJ	B-NP	B-protein
sulfate	sulfate	NN	I-NP	I-protein
325	325	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Prozac	Prozac	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Neurontin	Neurontin	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
post-dialysis	post-dialysis	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Motrin	Motrin	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
every	every	DT	B-NP	O
eight	eight	CD	I-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
10	10	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
nightly	nightly	RB	B-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
regular	regular	JJ	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

See	See	VB	B-VP	O
discharge	discharge	NN	B-NP	O
order	order	NN	I-NP	O
for	for	IN	B-PP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Atrovent	Atrovent	IN	B-PP	O
2	2	CD	B-NP	O
puffs	puff	NNS	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
Do	Do	NNP	B-NP	O
not	not	RB	O	O
take	take	VB	B-VP	O
with	with	IN	B-PP	O
lightheadedness	lightheadedness	NN	B-NP	O
or	or	CC	I-NP	O
dizziness	dizziness	NN	I-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Metamucil	Metamucil	NN	B-NP	O
1	1	CD	I-NP	O
packet	packet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Sevelamer	Sevelamer	NN	B-NP	O
800	800	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
nightly	nightly	RB	I-ADVP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-7971059	1-7971059	CD	B-NP	O
HFFocus	HFFocus	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
BODE	BODE	NN	B-NP	O
,	,	,	O	O
NED	NED	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
STENT	STENT	NN	B-NP	O
,	,	,	O	O
PABLO	PABLO	NNP	B-NP	O
JARRED	JARRED	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
7998550	7998550	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
5/28/06	5/28/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/28/06	5/28/06	CD	B-NP	O

